Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension

Headache
A H Wheeler

Abstract

Pericranial muscle tension may contribute to the development of facial discomfort, chronic daily headache, and migraine-type headache. Elimination of pericranial muscle tension may reduce associated myalgia and counteract influences that can trigger secondary headaches which fall within the migraine continuum. Four patients with chronic, predominantly tension-type headaches and associated pericranial muscle tension failed prolonged conventional treatment and, therefore, symptomatic areas were treated with botulinum toxin A. This alleviated myalgia and reduced the severity and frequency of migraine-type headaches with a concomitant reduction in subsequent medical and physical therapy interventions. Judicious use of botulinum toxin A into defined areas of pericranial muscle tension may be useful for reducing primary myalgia and secondary headache.

Citations

Jun 8, 2001·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·J Teramoto
Jun 14, 2001·Current Pain and Headache Reports·D M Biondi
Oct 3, 2002·Current Pain and Headache Reports·M Vandenheede, Jean Schoenen
May 2, 2003·Current Pain and Headache Reports·Stefan Evers
Dec 6, 2001·Current Treatment Options in Neurology·Judy C. Lane, David B. Arciniegas
Oct 1, 2003·Current Treatment Options in Neurology·Charles E. Argoff
Sep 14, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C SwartlingH Naver
Nov 8, 2002·Cephalalgia : an International Journal of Headache·S EversI-W Husstedt
Apr 12, 2000·Headache·C Redillas, S Solomon
Dec 1, 2006·Pain Practice : the Official Journal of World Institute of Pain·M A Royal
Jul 8, 1999·The New England Journal of Medicine·M Hallett
Feb 7, 2003·The Clinical Journal of Pain·Elizabeth Loder, David Biondi
Aug 18, 2000·Plastic and Reconstructive Surgery·B GuyuronJ Davis
Mar 9, 2002·Plastic and Reconstructive Surgery·Alan MatarassoUNKNOWN American Society of Plastic Surgeons DATA Committee
Jun 5, 2002·Plastic and Reconstructive Surgery·Bahman GuyuronJanine Davis
Sep 27, 2003·Plastic and Reconstructive Surgery·UNKNOWN American Society of Plastic Surgeons, Executive Committee
May 29, 2004·Current Opinion in Otolaryngology & Head and Neck Surgery·Stefan Evers
Sep 25, 2003·Plastic and Reconstructive Surgery·Bahman GuyuronJennifer Kriegler
Jul 1, 2005·Plastic and Reconstructive Surgery·Saúl Amparán-Estrada
Jul 20, 2010·Plastic and Reconstructive Surgery·Jeffrey E JanisBahman Guyuron
Dec 23, 2003·Cephalalgia : an International Journal of Headache·W G OndoH S Derman
Jun 28, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Bhertha Miyuki Tamura, Bobby Chang
Mar 11, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Arnold William Klein
Mar 22, 2008·Ophthalmic Plastic and Reconstructive Surgery·Andrew R HarrisonMichael S Lee
Jun 28, 2000·Current Opinion in Neurology·R Jensen, J Olesen
Nov 11, 1999·Current Opinion in Neurology·A R Bentivoglio, A Albanese
May 17, 2006·Current Opinion in Neurology·Stefan Evers
Mar 15, 2006·Expert Review of Neurotherapeutics·Julia Samton, Alexander Mauskop
Feb 5, 2002·Expert Opinion on Pharmacotherapy·S D Silberstein
Aug 7, 2012·Expert Opinion on Emerging Drugs·Luana LionettoPaolo Martelletti
Apr 21, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Jasvinder A SinghSiamak Noorbaloochi
Jul 8, 2008·The Journal of Headache and Pain·Francesco Saverio MenniniPaolo Martelletti
Nov 26, 2008·The Journal of Headache and Pain·Sherif M HamdyRasha Hasan
Jul 28, 2001·Seminars in Cutaneous Medicine and Surgery·J VerheydenM F Brin
Jul 28, 2001·Seminars in Cutaneous Medicine and Surgery·W J BinderJ M Pogoda
Nov 30, 2006·Pain Practice : the Official Journal of World Institute of Pain·Stewart J Tepper
May 19, 2004·Headache·J N Blau
Jun 6, 2003·Headache·Randolph W Evans, Andrew Blumenfeld
Nov 8, 2007·Pain Practice : the Official Journal of World Institute of Pain·Leonardo KapuralNagy Mekhail
Jan 25, 2012·Headache·Andrew Blumenfeld, Randolph W Evans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.